BL0175

· Shanghai Best-Link Bioscience, LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BL0175, covering 2026-01-13 to 2026-01-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Single Dose of BL0175 in Postmenopausal Women [Phase 1]